Search
for
Sort by
Research 781–810 of 1000+
- Chitosan-decorated polystyrene-b-poly(acrylic acid) polymersomes as novel carriers for topical delivery of finasteride
- Alopecia areata and the gut—the link opens up for novel therapeutic interventions
- Types of Hair Loss and Treatment Options, Including the Novel Low-Level Light Therapy and Its Proposed Mechanism
- A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer
- PNU 157706, a novel dual type I and II5α-reductase inhibitor
- Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase.
- Fullerene C<sub>60</sub> with cytoprotective and cytotoxic potential: prospects as a novel treatment agent in Dermatology?
- <i>Curcuma aeruginosa</i>, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study
- Inhibitory effect of M50054, a novel inhibitor of apoptosis, on anti-Fas-antibody-induced hepatitis and chemotherapy-induced alopecia
- Loss of Memo, a novel FGFR regulator, results in reduced lifespan
- Application of Scaffold-Based Drug Delivery in Oral Cancer Treatment: A Novel Approach
- The Phenotypic and Genotypic Spectra of Ichthyosis With Confetti Plus Novel Genetic Variation in the 3′ End of<i>KRT10</i>
- Physcion, a novel inhibitor of 5α-reductase that promotes hair growth in vitro and in vivo
- 12-Chloracetyl-PPD, a novel dammarane derivative, shows anti-cancer activity via delay the progression of cell cycle G2/M phase and reactive oxygen species-mediate cell apoptosis
- Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
- Synthesis and biological evaluation of 3-tetrazolo steroidal analogs: Novel class of 5α-reductase inhibitors
- Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series
- Risk factors for diabetic foot ulcers mortality and novel negative pressure combined with platelet-rich plasma therapy in the treatment of diabetic foot ulcers
- Signal transducer and activator of transcription 5B deficiency due to a novel missense mutation in the coiled-coil domain
- Screening of synthetic and natural product databases: Identification of novel androgens and antiandrogens
- The ATP sensitive potassium channel (KATP) is a novel target for migraine drug development
- KY19382, a novel activator of Wnt/β‐catenin signalling, promotes hair regrowth and hair follicle neogenesis
- A genomic approach to susceptibility and pathogenesis leads to identifying potential novel therapeutic targets in androgenetic alopecia
- 3,3-Diphenylpentane skeleton as a steroid skeleton substitute: Novel inhibitors of human 5α-reductase 1
- Dutasteride, a novel dual 5-A reductase inhibitor, reduces serum DHT to a greater extent versus finasteride and achieves finasteride maximal reduction in a larger proportion of patients
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- Elucidating penetration pathways into the hair fiber using novel microscopic techniques.
- Patient experience in systemic lupus erythematosus: development of novel patient-reported symptom and patient-reported impact measures
- Process Development and Crystallization in Oiling-Out System of a Novel Topical Antiandrogen
- Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology